ALLIANCEBERNSTEIN L.P. - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 82 filers reported holding RHYTHM PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,246,891
+39.0%
54,3900.0%0.00%
Q2 2023$896,891
+73.5%
54,390
+21.1%
0.00%
Q1 2022$517,000
+15.7%
44,900
+0.2%
0.00%
Q4 2021$447,000
-17.7%
44,800
+7.7%
0.00%
Q3 2021$543,000
-33.4%
41,6000.0%0.00%
Q2 2021$815,000
-7.9%
41,6000.0%0.00%
Q1 2021$885,000
-25.8%
41,600
+3.7%
0.00%
-100.0%
Q4 2020$1,192,000
+37.2%
40,1000.0%0.00%
Q3 2020$869,000
-5.6%
40,100
-2.9%
0.00%
-100.0%
Q2 2020$921,000
+148.2%
41,300
+69.3%
0.00%
Q1 2020$371,000
-33.8%
24,4000.0%0.00%
Q4 2019$560,000
+11.8%
24,400
+5.2%
0.00%
Q3 2019$501,000
+21.9%
23,200
+24.1%
0.00%
Q2 2019$411,000
-4.4%
18,700
+19.1%
0.00%
Q1 2019$430,000
-3.6%
15,700
-5.4%
0.00%
Q4 2018$446,000
+20.5%
16,600
+30.7%
0.00%
Q3 2018$370,000
+62.3%
12,700
+74.0%
0.00%
Q2 2018$228,0007,3000.00%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 909,258$9,074,0001.96%
NEA Management Company, LLC 4,912,306$49,025,0000.99%
RA Capital Management 4,871,067$48,613,0000.86%
Samsara BioCapital, LLC 345,293$3,446,0000.67%
Endurant Capital Management LP 197,462$1,971,0000.48%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,867,467$18,637,0000.39%
ACT CAPITAL MANAGEMENT, LLC 27,500$274,0000.20%
Baker Brothers Advisors 3,863,239$38,555,0000.19%
Rock Springs Capital Management LP 627,180$6,259,0000.14%
Aquatic Capital Management LLC 4,000$40,0000.08%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders